Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 5, 2023
Celastrol targets the ChREBP-TXNIP axis to ameliorates type 2 diabetes mellitusDuanfang Zhou, Xiaoli Li, Xiaoqiu Xiao, et al.
Plos Genetics|October 14, 2020
Correction: Molecular predictors of brain metastasis-related microRNAs in lung adenocarcinomaGuogui Sun, Xiao Ding, Nan Bi, et al.
Elife|January 4, 2023
<i>Mir155</i> regulates osteogenesis and bone mass phenotype via targeting <i>S1pr1</i> geneZhichao Zheng, Lihong Wu, Zhicong Li, et al.
Frontiers in Immunology|March 11, 2024
Key candidate genes and pathways in T lymphoblastic leukemia/lymphoma identified by bioinformatics and serological analysesYansong Ren, Haoyue Liang, Yali Huang, et al.
Frontiers in Cell and Developmental Biology|August 8, 2020
SLIT2 Overexpression in Periodontitis Intensifies Inflammation and Alveolar Bone Loss, Possibly via the Activation of MAPK PathwayLiping Wang, Jing Zheng, Janak L Pathak, et al.
Frontiers in Pharmacology|May 16, 2022
Co-Crystal of Rosiglitazone With Berberine Ameliorates Hyperglycemia and Insulin Resistance Through the PI3K/AKT/TXNIP Pathway <i>In Vivo</i> and <i>In Vitro</i>Qichen He, Bo Chen, Gang Wang, et al.
Biochemical Pharmacology|January 29, 2024
CCT020312 exerts anti-prostate cancer effect by inducing G1 cell cycle arrest, apoptosis and autophagy through activation of PERK/eIF2α/ATF4/CHOP signalingDuanfang Zhou, Manjialan Yin, Baoguo Kang, et al.
Journal for Immunotherapy of Cancer|August 15, 2020
Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancerZhihao Lu, Huan Chen, Shuang Li, et al.
Communications Biology|January 29, 2026
PiR48444 inhibits MSC osteogenic differentiation and bone regeneration via targeting METTL7A/eIF4E-mediated BMP2 m6A methylationZhichao Zheng, Xingyang Li, Wenguang Qin, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 14, 2020
The CD68+ macrophages to CD8+ T-cell ratio is associated with clinical outcomes in hepatitis B virus (HBV)-related hepatocellular carcinomaHaibei Xin, Dandan Liang, Minfeng Zhang, et al.
Pageof 20